CompanyOTCRed Bank, NJ

Hepion Pharmaceuticals, Inc

SEC EDGAR ClinicalTrials.gov

10-QOct 29Latest SEC filing, period to Sep 30

Form DAug 5$3.1M sold

October 2026

Hepion Pharmaceuticals acquires Gravitas Life Sciences, installs new CEO

Oct 9M&AHepion Pharmaceuticals, Inc